Barclays »

Mink Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $45 4 11.25

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Geode Capital Management
Renaissance Technologies
UBS Group
BlackRock
Tower Research Capital
Covestor
Advisor Group Holdings
Wells Fargo & Company
Northwestern Mutual Wealth Management Company
Bnp Paribas Arbitrage, Snc
Game Plan Financial Advisors
Hartland & Co
Jpmorgan Chase & Co

View all funds holding Mink Therapeutics